Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Decellularization and Recellularization of Natural, Benign Prostatic Hyperplasia and Malignant Human Prostatic Tissues: Role of Extracellular Matrix Behavior on Development of Prostate Cancer Publisher



Kajbafzadeh AM1 ; Jafarnezhadansariha F1 ; Sharifi SHH1 ; Sabetkish S1 ; Parvin M2 ; Tabatabaei S3 ; Fendereski K1 ; Akbarzadeh A1 ; Ladiseyedian SS1 ; Mohammadnejad A4, 5 ; Nabavizadeh B1 ; Razavi AE4, 5 ; Esmaeilipour R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Institute, Children’s Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, 1419733151, Iran
  2. 2. Department of Uropathology, Shahid Labafinejad Medical Center Urology Center of Excellence, Shahid Beheshti University of Medical Sciences, IRI, Tehran, Iran
  3. 3. Department of Urology, Massachusetts General Hospital, Boston, MA, United States
  4. 4. Cancer Models Research Center, Cancer Institute of Iran, Cancer Biology Research Center, Pathology, Iranian Cancer Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, IRI, Tehran, Iran
  5. 5. Clinical Biochemistry, Iran National Tumor Bank, Cancer Institute, Tehran University of Medical Sciences, IRI, Tehran, Iran

Source: Regenerative Engineering and Translational Medicine Published:2023


Abstract

Purpose: We focused on the composition and architecture of the prostate extracellular matrix (ECM) and interactions with its cellular constituents. We also discussed the role of ECM remodeling on cellular behaviors in vivo. Methods: Nine natural, BPH, and malignant human prostate tissues were decellularized using a modified technique. Then, the scaffolds were implanted adjacent to the prostate in nine male GFP-positive rats which were randomly divided into group A (n = 3, natural), group B (n = 3, BPH), and group C (n = 3, malignant tissue). Biopsies were taken after six months of implantation to assess the quality of recellularization by histological evaluations. We also evaluated the impact of malignant and BPH prostatic ECM on cell proliferation, differentiation, and expression of ECM components in follow-up. Results: Cell removal with preservation of ECM structure was confirmed in all decellularized prostates. Histological examinations after the decellularization process illustrated down-regulated expression of laminin and vimentin in normal, BPH, and malignant tissues. Furthermore, malignant samples revealed simply lower levels in type IV Collagen content of the ECM. All of the implanted samples also contained an abundance of newly formed vessels suggestive of prominent angiogenesis. Immunostaining of all scaffolds after implantation was negative for AMACR marker revealing the absence of cancerous cells in the recellularized tissues in follow-up. The samples in group C demonstrated the highest decrease in the ECM content after recellularization. Conclusion: The outcomes could bring us one step closer to understanding the complex dynamics of ECM–cell interactions in prostate adenocarcinoma. We concluded that the expression of some markers may change in malignant human prostatic tissues after the decellularization process. Lay summary: Previously, we used recellularization of testicular feminization testis in C57bl6 as a natural bio-reactor for the creation of cellularized seminiferous tubules. In this study, we try to evaluate the composition and architecture of the prostate ECM and its interactions with its cellular constituents. We also aim to assess the role of ECM remodeling on cellular behaviors in vivo. Future works: We will emphasize on assessing in vitro and in vivo characteristics of bio-scaffolds from diverse benign and malignant tissues. We will also examine the role of ECM behavior on the development of prostate cancer in our long-term follow-ups. © 2023, The Author(s), under exclusive licence to The Regenerative Engineering Society.